Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke.
Completed
Phase N/A ResultsReferences
Source for Trial Information
- Ann Intern Med 1986;105:825-828.
Recruitment
- Gender: Both
- Study Size: 225
- Number of Centers: 3
- Max Time from Onset: 48 Hours
- Follow Up: 1 Years
Principal Investigator
-
Robert J. Duke, M.D.
McMaster University Department of Medicine.
Locations
- Hamilton, Ontario; Toronto, Ontario